Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08ODH
|
||||
| Former ID |
DIB002306
|
||||
| Drug Name |
Atiratecan
|
||||
| Synonyms |
CH-0793011; CH-0793076; CH-4556300; TP-300
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Colorectal cancer [ICD9: 153, 154; ICD10:C18-C21] | Discontinued in Phase 2 | [548306] | ||
| Company |
Chugai Pharmaceutical Co Ltd
|
||||
| Formula |
C31H34N6O6
|
||||
| Canonical SMILES |
c1ccc2nc3c(c4c2c1ncn4CCCCC)Cn1c3cc2c(c1=O)COC(=O)[C@@]2<br />(CC)OC(=O)CN(C(=O)CN)C
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Toposisomerase-1 | Target Info | Inhibitor | [531647] | |
| NetPath Pathway | IL2 Signaling Pathway | ||||
| PANTHER Pathway | DNA replication | ||||
| Pathway Interaction Database | Caspase Cascade in Apoptosis | ||||
| WikiPathways | Integrated Pancreatic Cancer Pathway | ||||
| References | |||||
| Ref 531647 | Method development and validation of the simultaneous determination of a novel topoisomerase 1 inhibitor, the prodrug, and the active metabolite in human plasma using column-switching LC-MS/MS, and its application in a clinical trial. J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Nov 15;879(30):3415-22. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.